Truist Financial Corp Atri Cure, Inc. Transaction History

Truist Financial Corp

$71.8 Billion
Q3 2025

A detailed history of Truist Financial Corp transactions in Atri Cure, Inc. stock. As of the latest transaction made, Truist Financial Corp holds 20,960 shares of ATRC stock, worth $724,167. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,960

Previous 21,206 1.16%

Holding current value

$724,167

Previous $694,000 6.34%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 03, 2025	SELL	$29.24 - $37.87 $7,193 - $9,316	-246 Reduced 1.16%	20,960 $738,000
Q2 2025 Jul 18, 2025	BUY	$29.07 - $34.94 $63,895 - $76,798	2,198 Added 11.56%	21,206 $694,000
Q1 2025 Apr 29, 2025	BUY	$30.4 - $42.4 $100,046 - $139,538	3,291 Added 20.94%	19,008 $613,000
Q4 2024 Jan 31, 2025	BUY	$27.02 - $38.2 $10,889 - $15,394	403 Added 2.63%	15,717 $480,000
Q3 2024 Nov 13, 2024	BUY	$20.34 - $29.5 $2,644 - $3,835	130 Added 0.86%	15,314 $429,000
Q2 2024 Aug 20, 2024	BUY	$19.86 - $29.09 $36,582 - $53,583	1,842 Added 13.81%	15,184 $345,000
Q1 2024 May 10, 2024	BUY	$28.21 - $37.78 $11,904 - $15,943	422 Added 3.27%	13,342 $405,000
Q4 2023 Feb 02, 2024	SELL	$32.99 - $43.25 $83,827 - $109,898	-2,541 Reduced 16.43%	12,920 $461,000
Q3 2023 Nov 14, 2023	SELL	$41.12 - $57.73 $1,028 - $1,443	-25 Reduced 0.16%	15,461 $677,000
Q2 2023 Aug 01, 2023	SELL	$40.44 - $49.6 $42,057 - $51,584	-1,040 Reduced 6.29%	15,486 $764,000
Q1 2023 May 05, 2023	SELL	$35.87 - $47.22 $146,457 - $192,799	-4,083 Reduced 19.81%	16,526 $685,000
Q4 2022 Feb 17, 2023	SELL	$33.48 - $47.45 $200,478 - $284,130	-5,988 Reduced 22.51%	20,609 $914,000
Q3 2022 Oct 26, 2022	BUY	$38.25 - $52.62 $60,205 - $82,823	1,574 Added 6.29%	26,597 $1.04 Million
Q2 2022 Jul 22, 2022	BUY	$35.1 - $66.01 $139,031 - $261,465	3,961 Added 18.81%	25,023 $1.02 Million
Q1 2022 Apr 22, 2022	BUY	$57.43 - $71.39 $10,624 - $13,207	185 Added 0.89%	21,062 $1.38 Million
Q4 2021 Feb 14, 2022	BUY	$63.4 - $87.14 $57,503 - $79,035	907 Added 4.54%	20,877 $1.45 Million
Q3 2021 Nov 05, 2021	SELL	$69.28 - $84.46 $17,112 - $20,861	-247 Reduced 1.22%	19,970 $1.39 Million
Q2 2021 Aug 16, 2021	BUY	$64.13 - $80.18 $93,886 - $117,383	1,464 Added 7.81%	20,217 $1.6 Million
Q1 2021 May 17, 2021	BUY	$53.79 - $66.98 $651,612 - $811,395	12,114 Added 182.47%	18,753 $1.23 Million
Q4 2020 Nov 19, 2021	SELL	$34.56 - $57.55 $108,691 - $180,994	-3,145 Reduced 32.14%	6,639 $370,000
Q4 2020 Feb 18, 2021	BUY	$34.56 - $57.55 $126,420 - $210,517	3,658 Added 59.71%	9,784 $545,000
Q3 2020 Nov 13, 2020	BUY	$38.36 - $46.91 $32,260 - $39,451	841 Added 15.91%	6,126 $245,000
Q2 2020 Aug 14, 2020	BUY	$31.78 - $51.19 $167,957 - $270,539	5,285 New	5,285 $238,000

Others Institutions Holding ATRC

# of Institutions

224

Shares Held

52.2M

Call Options Held

33.5K

Put Options Held

View Full List

About AtriCure, Inc.

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.6B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

More about ATRC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Account

Truist Financial Corp Atri Cure, Inc. Transaction History